Evidence map›Paper›PMID 40160473›Full record

ArticleFrontiers in cellular and infection microbiology2025

Polyclonal carbapenemase-producing

Vittoria Mattioni Marchetti, Marta Corbella, Aurora Piazza, Stefano Gaiarsa, Irene Mileto, Cristina Merla, Angela Kuka, Aseel AbuAlshaar, Patrizia Cambieri, Roberta Migliavacca and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vittoria Mattioni MarchettiDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.
Marta CorbellaMicrobiology and Virology Unit, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Aurora PiazzaDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.
Stefano GaiarsaMicrobiology and Virology Unit, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Irene MiletoSpecialization School of Microbiology and Virology, University of Pavia, Pavia, Italy.
Cristina MerlaMicrobiology and Virology Unit, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Angela KukaSpecialization School of Microbiology and Virology, University of Pavia, Pavia, Italy.
Aseel AbuAlshaarDepartment of Biology and Biotechnology, American University of Madaba, Madaba, Jordan.
Patrizia CambieriMicrobiology and Virology Unit, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
Roberta MigliavaccaDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.
Fausto BaldantiDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spread of extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing

Indexed as

Bacterial Proteinsbeta-LactamasesEscherichia coliEscherichia coli InfectionsAnimalsAnti-Bacterial AgentsHumansItalyMicrobial Sensitivity TestsVirulence FactorsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseVirulence FactorscarbapenemasesEscherichia coliIncX3NDM-7ST355ST401virulenceWGS

Identifiers

PMID40160473
PMCPMC11949906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.